Literature DB >> 25724728

Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages.

María D Ruis-González1, María D Cañete2, José L Gómez-Chaparro3, Nieves Abril4, Ramón Cañete5, Juan López-Barea6.   

Abstract

Intrauterine growth restriction (IUGR) is associated with increased morbidity and metabolic anomalies in adults. The serum proteome of venous blood was compared in 43 IUGR and 45 adequate gestational age (AGA) infants, separated into three gestational age groups, "Very Preterm" 29-32weeks, "Moderate Preterm" 33-36w, and, "Term" ≥37weeks, in samples drawn three times from birth to 1month of life. After depleting the abundant serum proteins (ProteoMiner(TM)), expression changes were studied by 2-DE, image analysis (Proteomweaver 4.0(TM)), and identification by MALDI-TOF/TOF. Significant expression differences were found in thirty-four proteins, and thirty-three were identified. Lysophospholipid acyltransferase 7 (MBOAT7), was detected exclusively in IUGR of all gestational ages and sampling times; seven other proteins were found only in AGA. Another twenty-five proteins had intensity changes ≥2.5 folds in IUGR: twenty were upregulated and five downregulated. Western blots confirmed the identification of several proteins: MBOAT7 increased 20.5-fold in IUGR, while AGA had 11.2-fold higher levels of SUMO3 and sumoylated proteins and 13.7-fold higher levels of APOL1. Upregulation of MBOAT7 in IUGR neonates could be an adaptive response to protect the brain from an adverse environment. BIOLOGICAL SIGNIFICANCE: There are significant protein expression differences between IUGR and AGA at different gestational age groups and blood extraction times. The extensive upregulation of lysophospholipid acyltransferase 7 in all IUGR gestational ages and extraction times might be an adaptative response to an adverse fetal environment, reminiscent of Barker's fetal programming theory. Two serotransferrins were also upregulated in IUGR of all gestational ages. Just at birth "Very Preterm" IUGR showed nine upregulated proteins, including five albumins, apolipoprotein E, keratin type I cytoskeletal 10, solute carrier family member 2 fragment, and anaphase-promoting complex subunit 2.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human newborn; Intrauterine growth restriction; Proteomics; Venous blood serum proteins

Mesh:

Substances:

Year:  2015        PMID: 25724728     DOI: 10.1016/j.jprot.2015.02.003

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  9 in total

1.  APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Authors:  Leslie A Bruggeman; Zhenzhen Wu; Liping Luo; Sethu M Madhavan; Martha Konieczkowski; Paul E Drawz; David B Thomas; Laura Barisoni; John R Sedor; John F O'Toole
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

2.  Novel Plasma Proteins in Nepalese School-aged Children are Associated with a Small Head Size at Birth.

Authors:  Sun Eun Lee; Keith P West; Robert N Cole; Kerry J Schulze; Lee S-F Wu; James D Yager; John Groopman; Parul Christian
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

3.  Association of preeclampsia with infant APOL1 genotype in African Americans.

Authors:  Anna K Miller; Timur Azhibekov; John F O'Toole; John R Sedor; Scott M Williams; Raymond W Redline; Leslie A Bruggeman
Journal:  BMC Med Genet       Date:  2020-05-20       Impact factor: 2.103

Review 4.  MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD.

Authors:  Marica Meroni; Miriam Longo; Anna L Fracanzani; Paola Dongiovanni
Journal:  EBioMedicine       Date:  2020-07-03       Impact factor: 8.143

5.  Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling.

Authors:  Mariona Guitart-Mampel; Diana L Juarez-Flores; Lina Youssef; Constanza Moren; Laura Garcia-Otero; Vicente Roca-Agujetas; Marc Catalan-Garcia; Ingrid Gonzalez-Casacuberta; Ester Tobias; José C Milisenda; Josep M Grau; Fàtima Crispi; Eduard Gratacos; Francesc Cardellach; Glòria Garrabou
Journal:  J Cell Mol Med       Date:  2019-04-02       Impact factor: 5.310

Review 6.  The use of proteomics for blood biomarker research in premature infants: a scoping review.

Authors:  Natasha Letunica; Tengyi Cai; Jeanie L Y Cheong; Lex W Doyle; Paul Monagle; Vera Ignjatovic
Journal:  Clin Proteomics       Date:  2021-04-14       Impact factor: 3.988

7.  Morbility, clinical data and proteomic analysis of IUGR and AGA newborns at different gestational ages.

Authors:  M D Ruiz-González; M D Cañete; J L Gómez-Chaparro; A Rodríguez-Torronteras; N Abril; R Cañete; J L López-Barea
Journal:  Data Brief       Date:  2016-09-21

8.  Gender-specific effects of intrauterine growth restriction on the adipose tissue of adult rats: a proteomic approach.

Authors:  Adriana Pereira de Souza; Amanda Paula Pedroso; Regina Lúcia Harumi Watanabe; Ana Paula Segantine Dornellas; Valter Tadeu Boldarine; Helen Julie Laure; Claudia Maria Oller do Nascimento; Lila Missae Oyama; José Cesar Rosa; Eliane Beraldi Ribeiro
Journal:  Proteome Sci       Date:  2015-12-02       Impact factor: 2.480

9.  Developmental origins of metabolic disorders: The need for biomarker candidates and therapeutic targets from adequate preclinical models.

Authors:  Antonio Gonzalez-Bulnes; Susana Astiz; Marta Vazquez-Gomez; Consolación Garcia-Contreras
Journal:  EuPA Open Proteom       Date:  2016-01-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.